98 related articles for article (PubMed ID: 35962198)
1. Engineered Cas13 variants with minimal collateral RNA targeting.
Nat Biotechnol; 2023 Jan; 41(1):29-30. PubMed ID: 35962198
[No Abstract] [Full Text] [Related]
2. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.
Tong H; Huang J; Xiao Q; He B; Dong X; Liu Y; Yang X; Han D; Wang Z; Wang X; Ying W; Zhang R; Wei Y; Xu C; Zhou Y; Li Y; Cai M; Wang Q; Xue M; Li G; Fang K; Zhang H; Yang H
Nat Biotechnol; 2023 Jan; 41(1):108-119. PubMed ID: 35953673
[TBL] [Abstract][Full Text] [Related]
3. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
Huynh N; Depner N; Larson R; King-Jones K
Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
[TBL] [Abstract][Full Text] [Related]
4. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
Meeske AJ; Nakandakari-Higa S; Marraffini LA
Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
[TBL] [Abstract][Full Text] [Related]
5. The double life of CRISPR-Cas13.
Bot JF; van der Oost J; Geijsen N
Curr Opin Biotechnol; 2022 Dec; 78():102789. PubMed ID: 36115160
[TBL] [Abstract][Full Text] [Related]
6. The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons.
Wu QW; Kapfhammer JP
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916905
[TBL] [Abstract][Full Text] [Related]
7. RNA-Targeting CRISPR-Cas Systems and Their Applications.
Burmistrz M; Krakowski K; Krawczyk-Balska A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
[TBL] [Abstract][Full Text] [Related]
8. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
Kavuri NR; Ramasamy M; Qi Y; Mandadi K
Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
[TBL] [Abstract][Full Text] [Related]
9. Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.
Özcan A; Krajeski R; Ioannidi E; Lee B; Gardner A; Makarova KS; Koonin EV; Abudayyeh OO; Gootenberg JS
Nature; 2021 Sep; 597(7878):720-725. PubMed ID: 34489594
[TBL] [Abstract][Full Text] [Related]
10. Programmable Inhibition and Detection of RNA Viruses Using Cas13.
Freije CA; Myhrvold C; Boehm CK; Lin AE; Welch NL; Carter A; Metsky HC; Luo CY; Abudayyeh OO; Gootenberg JS; Yozwiak NL; Zhang F; Sabeti PC
Mol Cell; 2019 Dec; 76(5):826-837.e11. PubMed ID: 31607545
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
Wu S; Tian P; Tan T
Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
[TBL] [Abstract][Full Text] [Related]
12. Precise Genome Editing of Drosophila with CRISPR RNA-Guided Cas9.
Gratz SJ; Harrison MM; Wildonger J; O'Connor-Giles KM
Methods Mol Biol; 2015; 1311():335-48. PubMed ID: 25981484
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
[TBL] [Abstract][Full Text] [Related]
14. Rapidly Characterizing CRISPR-Cas13 Nucleases Using Cell-Free Transcription-Translation Systems.
Wandera KG; Beisel CL
Methods Mol Biol; 2022; 2404():135-153. PubMed ID: 34694607
[TBL] [Abstract][Full Text] [Related]
15. Pathogen detection in the CRISPR-Cas era.
Sashital DG
Genome Med; 2018 Apr; 10(1):32. PubMed ID: 29690921
[TBL] [Abstract][Full Text] [Related]
16. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
17. Compact RNA editors with small Cas13 proteins.
Kannan S; Altae-Tran H; Jin X; Madigan VJ; Oshiro R; Makarova KS; Koonin EV; Zhang F
Nat Biotechnol; 2022 Feb; 40(2):194-197. PubMed ID: 34462587
[TBL] [Abstract][Full Text] [Related]
18. A robust CRISPR-Cas12a biosensor coated with metal-organic framework.
Sha L; Han Y; Wang M; Wu S; Yang J; Li G
J Mater Chem B; 2021 Jul; 9(27):5451-5455. PubMed ID: 34184004
[TBL] [Abstract][Full Text] [Related]
19. Applications of the versatile CRISPR-Cas13 RNA targeting system.
Kordyś M; Sen R; Warkocki Z
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
[TBL] [Abstract][Full Text] [Related]
20. A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
Li PY; Li SQ; Gao SG; Dong DY
Med Hypotheses; 2022 Feb; 159():110754. PubMed ID: 35002020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
